Results 31 to 40 of about 1,888 (198)
Characterization of two polymorphs of lornoxicam
Journal of Pharmacy and Pharmacology, 2013 Abstract Objectives The aim of the study was to prepare and to characterize two polymorphs of lornoxicam, a water-insoluble non-steroidal anti-inflammatory drug, which has thus far received no exploration of its polymorphs.
Jianjun, Zhang +5 more
openaire +2 more sources
LORNOXICAM: A REVIEW OF ITS THERAPEUTIC POTENTIAL IN DIFFERENT CLINICAL STUDIES [PDF]
, 2013 Lornoxicam is a member of the oxicam group of nonsteroidal antiinflammatory drugs (NSAIDs), producing analgesic and antipyretic effects  through the non-selective inhibition of cyclo-oxygenase-1 and -2.
Srivastava, R K +3 more
core +1 more source
Physicochemical characterization of lornoxicam gels F1-F9 (n = 3).
, 2020 Physicochemical characterization of lornoxicam gels F1-F9 (n = 3).
Muhammad Harris Shoaib (5706638) +3 more
core +1 more source
Journal of Indian Academy of Oral Medicine and Radiology, 2022 Background: Mouth dissolving film (MDF) is a fast-dissolving drug delivery system that provides a practical means to administer drugs not just to special populations with swallowing difficulties but also to the general public. MDFs are novel dosage forms
M Aparna Vijayan +2 more
doaj +1 more source
Composition of lornoxicam gel for membrane-based transdermal patches.
, 2020 Composition of lornoxicam gel for membrane-based transdermal patches.
Muhammad Harris Shoaib (5706638) +3 more
core +1 more source
Acta Orthopaedica et Traumatologica Turcica, 2020 Objective: The aim of this study was to compare the analgesic effects of intra-articular levobupivacaine alone, intra-articular levobupivacaine in combination with lornoxicam, and intra-articular levobupivacaine in combination with lornoxicam and ...
Onder Ersan +3 more
doaj +1 more source
Permeation parameters of lornoxicam reservoir patches (F1-F9).
, 2020 Permeation parameters of lornoxicam reservoir patches (F1-F9).
Muhammad Harris Shoaib (5706638) +3 more
core +1 more source
Journal of Postgraduate Medicine, 2013 A patient started on 8 mg lornoxicam twice daily for pain in the hips developed acute-onset scalp hair loss. History and clinical examination revealed no evident abnormalities. Temporal association of the onset of hair loss with the use of lornoxicam, inability to explain hair loss by alternate causes, possibility of hair loss
M S, Keny, R R, Ghodge, S M, Bandekar
openaire +2 more sources
Hell's Itch: A Self‐Case Report
JEADV Clinical Practice, Volume 5, Issue 3, Page 982-985, September 2026.ABSTRACT Hell's itch is a severely distressing dermatological condition characterized by the onset of incessant itching and intolerable pain 2–3 days post‐sunburn. It is underdiagnosed and underreported, and no definitive management framework has yet been developed.
Kai Peter Moors, Willem I. Visser
wiley +1 more source
Functionalizing Conductive Diamond: Recent Advance in Fabrication, Modifications, and Applications
Carbon Energy, Volume 8, Issue 5, May 2026.This review highlights recent advancements in the synthesis, modification, and electrochemical applications of conductive diamond, particularly boron‐doped diamond (BDD). It emphasizes progress in fabrication methods, including CVD and HPHT, and explores modifications such as doping, surface terminations, and composite design, enabling significant ...
Ning Linghu, Xin Jiang, Jing Xu
wiley +1 more source